These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6834385)

  • 61. Effects of 4-(p-sulfamoylbenzoyl)-N-methyl-piperidine and related compounds on rat gastric acid secretion.
    Pinelli A; Colombo R; Muserra-Grandi G
    Pharmacol Res Commun; 1981 May; 13(5):517-24. PubMed ID: 7291280
    [No Abstract]   [Full Text] [Related]  

  • 62. 18-cycloalkyl analogues of enisoprost.
    Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Jones PH; Bauer RF
    J Med Chem; 1989 May; 32(5):1001-6. PubMed ID: 2709370
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors.
    Gibson RE; Rzeszotarski WJ; Eckelman WC; Jagoda EM; Weckstein DJ; Reba RC
    Biochem Pharmacol; 1983 Jun; 32(12):1851-6. PubMed ID: 6882462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Weak binding of 10-hydroxymetabolites of nortriptyline to rat brain muscarinic acetylcholine receptors.
    Wägner A; Ekqvist B; Bertilsson L; Sjöqvist F
    Life Sci; 1984 Sep; 35(13):1379-83. PubMed ID: 6482660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Muscarinic cholinoceptor regulation of cyclic guanosine monophosphate in human corneal epithelium.
    Walkenbach RJ; Ye GS
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):610-5. PubMed ID: 1848211
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Muscarinic receptor binding is inhibited by quinacrine.
    O'Donnell KA; Howlett AC
    Neurosci Lett; 1991 Jun; 127(1):46-8. PubMed ID: 1652714
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design, synthesis, and preliminary activity evaluation of novel pyrimidine derivatives as acid pump antagonists.
    Song W; Zhang X; Li S; Xu W
    Chem Biol Drug Des; 2015 Mar; 85(3):306-14. PubMed ID: 24995399
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The interaction of trazodone with rat brain muscarinic cholinoceptors.
    Hyslop DK; Taylor DP
    Br J Pharmacol; 1980; 71(2):359-61. PubMed ID: 7470750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH; Goldstein D
    J Pharmacol Exp Ther; 1986 Aug; 238(2):580-6. PubMed ID: 3016242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of food stimulated acid secretion by fenoctimine, a new anti-secretory agent.
    Williams JG; Robertson RJ; Milton-Thompson GJ
    Br J Clin Pharmacol; 1983 Jun; 15(6):673-6. PubMed ID: 6871066
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Muscarinic acetylcholine receptor regulation by accelerated rate of receptor loss.
    Klein WL; Nathanson N; Nirenberg M
    Biochem Biophys Res Commun; 1979 Sep; 90(2):506-12. PubMed ID: 508317
    [No Abstract]   [Full Text] [Related]  

  • 78. Interaction of iodinated quinuclidinyl benzilate enantiomers with M3 muscarinic receptors.
    Hiramatsu Y; Eckelman WC; Baum BJ
    Life Sci; 1994; 54(23):1777-83. PubMed ID: 8196491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of urea-treatment on agonist binding affinity of the muscarinic acetylcholine receptor.
    Matsumoto K; Uchida S; Higuchi H; Mizushima A; Yoshida H
    Life Sci; 1983 Sep; 33(10):963-70. PubMed ID: 6888158
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gastric antisecretory agents. 2. Antisecretory activity of 9-[(aminoalkyl)thio]-9H-xanthenes and 5-[(aminoalkyl)thio]-5H-[1]benzopyrano[2,3-b]pyridines.
    Bristol JA; Gold EH; Gross I; Lovey RG; Long JF
    J Med Chem; 1981 Aug; 24(8):1010-3. PubMed ID: 7328593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.